4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine, 90.0%, 2.5g

2,2,6-Trimethylcyclohexane-1,4-dione, 95.0%, 250mg

GC capillary column ROTI®Cap-5, 30 m, 0.53 mm, 1.00 µm, 1 Piece(s)

2-HYDRAZINO-1-METHYLPYRIDINIUM TOSYLATE, 95.0%, 1g

2-(3,5-Bis(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100g

(2R,3R,4S,5R)-2-(6-Amino-8-iodo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97%, 100mg

2-Bromo-m-xylene>98.0%(GC)250g

4-ACETYL-2-METHOXYBENZONITRILE, 95.0%, 1g

tert-Butyl(2-iodoethoxy)dimethylsilane>97.0%(GC)1g

2-[4-(4-Amino-benzenesulfonyl)-piperazin-1-yl]-ethanol, 250mg

(S)-4-(tert-Butoxy)-2-isopropyl-4-oxobutanoic acid, 95.0%, 250mg

2-(1-(Prop-2-yn-1-yl)piperidin-4-yl)acetic acid, 95%, 100mg

n-Benzyl-4-methoxybenzene-1-sulfonamide, 95%, 500mg